Schonfeld Strategic Advisors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Buy
+3,046
New +$219K ﹤0.01% 2149
2024
Q3
– Sell
-10,275
Closed -$449K – 2279
2024
Q2
$449K Sell
10,275
-2,035
-17% -$98.3K ﹤0.01% 1531
2024
Q1
$587K Buy
+12,310
New +$553K ﹤0.01% 1419
2020
Q4
– Sell
-5,400
Closed -$267K – 1770
2020
Q3
$267K Buy
5,400
+600
+13% +$33.9K 0.01% 1129
2020
Q2
$253K Buy
+4,800
New +$228K 0.01% 1048
2020
Q1
– Sell
-5,300
Closed -$463K – 1386
2019
Q4
$463K Buy
5,300
+1,400
+36% +$122K 0.01% 775
2019
Q3
$331K Buy
+3,900
New +$347K 0.01% 758
2019
Q2
– Sell
-4,879
Closed -$516K – 1167
2019
Q1
$516K Buy
+4,879
New +$490K 0.02% 682
2018
Q1
– Sell
-4,671
Closed -$329K – 912
2017
Q4
$329K Buy
+4,671
New +$337K 0.03% 561

Other funds holding NGVT

Schonfeld Strategic Advisors's NGVT Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Ingevity (NGVT) in Q2 2026: 3,046 shares worth $227K. The stake represents ﹤0.01% of the portfolio and ranks #2149 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in NGVT as recently as Q2 2024.

Schonfeld Strategic Advisors first reported a position in NGVT in Q4 2017 and has held it in 9 quarters since. The position peaked at $587K in Q1 2024. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Schonfeld Strategic Advisors held 3,046 shares of Ingevity worth $227K as of Q2 2026.
  • Ingevity was a new Schonfeld Strategic Advisors position in Q2 2026.
  • Ingevity made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #2149 holding.
  • Schonfeld Strategic Advisors first reported a position in Ingevity in Q4 2017 and has held it in 9 quarters since.
  • Schonfeld Strategic Advisors's Ingevity position peaked at $587K in Q1 2024.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.